The in vivo functions of a histidine-rich protein Hpn in Helicobacter pylori: Linking gastric and Alzheimer's diseases together?

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 788-790

  Ge, Ruiguang ^a   Sun, Xuesong ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; PROTEIN; PROTEIN HPN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BACTERIAL COLONIZATION; EPITHELIUM CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IN VIVO STUDY; PATHOLOGY; STOMACH DISEASE; STOMACH EPITHELIUM;

ALZHEIMER DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTEINS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 80053954876     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.038     Document Type: Article

References (45)

1. Ross C.A., Poirier M.A. Opinion: what is the role of protein aggregation in neurodegeneration?. Nat Rev Mol Cell Biol 2005, 6:891-898.
2. Walsh D.M., Klyubin I., Fadeeva J.V., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
3. Bush A.I., Pettingell W.H., Multhaup G., et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 1994, 265:1464-1467.
4. Huang X., Cuajungco M.P., Atwood C.S., et al. Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 1999, 274:37111-37116.
5. Yoshiike Y., Tanemura K., Murayama O., et al. New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity. J Biol Chem 2001, 276:32293-32299.
6. Gusella J.F., MacDonald M.E. Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 2000, 1:109-115.
7. Colombo G., Meli M., de Simone A. Computational studies of the structure, dynamics and native content of amyloid-like fibrils of ribonuclease A. Proteins 2008, 70:863-872.
8. Ge R., Watt R.M., Sun X., et al. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni2+ storage in Helicobacter pylori. Biochem J 2006, 393:285-293.
9. Suk J.Y., Kim Y.S., Park W.J. HRC (histidine-rich Ca2+ binding protein) resides in the lumen of sarcoplasmic reticulum as a multimer. Biochem Biophys Res Commun 1999, 263:667-671.
10. Sinha S.C., Chaudhuri B.N., Burgner J.W., et al. Crystal structure of imidazole glycerol-phosphate dehydratase: duplication of an unusual fold. J Biol Chem 2004, 279:15491-15498.
11. Ancsin J.B. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid 2003, 10:67-79.
12. Elimova E., Kisilevsky R., Ancsin J.B. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB J 2009, 23:3436-3448.
13. Blaser M.J. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987, 93:371-383.
14. Forman D., Newell D.G., Fullerton F., et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991, 302:1302-1305.
15. Parsonnet J., Hansen S., Rodriguez L., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994, 330:1267-1271.
16. Kountouras J., Tsolaki M., Gavalas E., et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006, 66:938-940.
17. Kountouras J., Gavalas E., Zavos C., et al. Alzheimer's disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med Hypotheses 2007, 68:378-388.
18. Honjo K., van Reekum R., Verhoeff N.P. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease?. Alzheimers Dement 2009, 5:348-360.
19. Gilbert J.V., Ramakrishna J., Sunderman F.W., et al. Protein Hpn: cloning and characterization of a histidine-rich metal-binding polypeptide in Helicobacter pylori and Helicobacter mustelae. Infect Immun 1995, 63:2682-2688.
20. Ge R., Sun X., Wang D., et al. Histidine-rich protein Hpn from Helicobacter pylori form as amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells. Biochim Biophys Acta 2011, 1813:1422-1427.
21. Parsons J.T., Horwitz A.R., Schwartz M.A. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010, 11:633-643.
22. Kountouras J., Boziki M., Gavalas E., et al. Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients. Cogn Behav Neurol 2010, 23:199-204.
23. Malaguarnera M., Bella R., Alagona G., et al. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med 2004, 15:381-386.
24. Ge R., Zhang Y., Sun X., et al. Thermodynamic and kinetic aspects of metal binding to the histidine-rich protein, Hpn. J Am Chem Soc 2006, 128:11330-11331.
25. Mehta N., Olson J.W., Maier R.J. Characterization of Helicobacter pylori nickel metabolism accessory proteins needed for maturation of both urease and hydrogenase. J Bacteriol 2003, 185:726-734.
26. Fu C., Olson J.W., Maier R.J. HypB protein of Bradyrhizobium japonicum is a metal-binding GTPase capable of binding 18 divalent nickel ions per dimer. Proc Natl Acad Sci USA 1995, 92:2333-2337.
27. Benoit S., Maier R.J. Dependence of Helicobacter pylori urease activity on the nickel-sequestering ability of the UreE accessory protein. J Bacteriol 2003, 185:4787-4795.
28. Kansau I., Guillain F., Thiberge J.M., Labigne A. Nickel binding and immunological properties of the C-terminal domain of the Helicobacter pylori GroES homologue (HspA). Mol Microbiol 1996, 22:1013-1023.
29. Stingl K., De Reuse H. Staying alive overdosed: how does Helicobacter pylori control urease activity?. Int J Med Microbiol 2005, 295:307-315.
30. Doherty G.J., McMahon H.T. Mediation, modulation, and consequences of membrane-cytoskeleton interactions. Annu Rev Biophys 2008, 37:65-95.
31. Green J.D., Kreplak L., Goldsbury C., et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. J Mol Biol 2004, 342:877-887.
32. Smith D.G., Cappai R., Barnham K.J. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 2007, 1768:1976-1990.
33. Kagan B.L., Thundimadathil J. Amyloid peptide pores and the beta sheet conformation. Adv Exp Med Biol 2010, 677:150-167.
34. Vanet A., Labigne A. Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins. Infect Immun 1998, 66:1023-1027.
35. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421.
36. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
37. O'Connor J.J., Coogan A.N. Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. Exp Physiol 1999, 84:601-614.
38. Shaftel S.S., Griffin W.S., O'Banion M.K. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 2008, 5:7.
39. Peek R.M., Fiske C., Wilson K.T. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev 2010, 90:831-858.
40. Deane R., Wu Z., Sagare A., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 2004, 43:333-344.
41. Yan S.D., Chen X., Fu J., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
42. Kayed R., Head E., Thompson J.L., et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
43. Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 2009, 8:16-30.
44. Shiota S., Murakami K., Yoshiiwa A., et al. The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol 2011, 10.1007/s00415-00011-05957-00415.
45. Kountouras J., Boziki M., Gavalas E., et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J Neurol 2009, 256:758-767.